CN101780026A - Eye shadow and eye line powder block and preparation method thereof - Google Patents
Eye shadow and eye line powder block and preparation method thereof Download PDFInfo
- Publication number
- CN101780026A CN101780026A CN 201010148669 CN201010148669A CN101780026A CN 101780026 A CN101780026 A CN 101780026A CN 201010148669 CN201010148669 CN 201010148669 CN 201010148669 A CN201010148669 A CN 201010148669A CN 101780026 A CN101780026 A CN 101780026A
- Authority
- CN
- China
- Prior art keywords
- eye
- powder
- eye shadow
- shadow
- lysine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000843 powder Substances 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000004472 Lysine Substances 0.000 claims abstract description 30
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 27
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 26
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 26
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 18
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 18
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 18
- 229920001577 copolymer Polymers 0.000 claims abstract description 17
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 13
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 13
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 13
- 229940046009 vitamin E Drugs 0.000 claims abstract description 13
- 239000011709 vitamin E Substances 0.000 claims abstract description 13
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims abstract description 12
- 229960001679 octinoxate Drugs 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 7
- 230000008569 process Effects 0.000 claims abstract description 4
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 33
- 244000293323 Cosmos caudatus Species 0.000 claims description 33
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 16
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 16
- 239000010703 silicon Substances 0.000 claims description 16
- 229910052710 silicon Inorganic materials 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 12
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 11
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 11
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 229920002545 silicone oil Polymers 0.000 claims description 9
- AMUTYVGRCVFCCD-UHFFFAOYSA-N 5,6-diaminopyridine-3-carboxylic acid Chemical compound NC1=CC(C(O)=O)=CN=C1N AMUTYVGRCVFCCD-UHFFFAOYSA-N 0.000 claims description 8
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims description 8
- 229940073609 bismuth oxychloride Drugs 0.000 claims description 8
- 229940008099 dimethicone Drugs 0.000 claims description 8
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 8
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 8
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 claims description 8
- 239000000377 silicon dioxide Substances 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 7
- 238000009725 powder blending Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 235000012239 silicon dioxide Nutrition 0.000 claims description 5
- 239000010445 mica Substances 0.000 claims description 4
- 229910052618 mica group Inorganic materials 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 44
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract description 31
- 230000006870 function Effects 0.000 abstract description 15
- 239000007788 liquid Substances 0.000 abstract description 7
- 230000032683 aging Effects 0.000 abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 4
- 230000003796 beauty Effects 0.000 abstract description 3
- 229960003646 lysine Drugs 0.000 abstract description 3
- 229960005196 titanium dioxide Drugs 0.000 abstract description 3
- 238000005034 decoration Methods 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 230000037072 sun protection Effects 0.000 abstract 1
- 235000018977 lysine Nutrition 0.000 description 24
- 239000000047 product Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 6
- 235000020776 essential amino acid Nutrition 0.000 description 5
- 239000003797 essential amino acid Substances 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical group O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- -1 sulfur aminoacid Chemical class 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 235000019766 L-Lysine Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000003255 anti-acne Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000011049 pearl Substances 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical class COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000382825 Cristaria plicata Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 241000879903 Pteria Species 0.000 description 1
- 208000032400 Retinal pigmentation Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010041303 Solar dermatitis Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 208000036654 deficiency anemia Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 235000012459 muffins Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 230000036417 physical growth Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- FEPMHVLSLDOMQC-UHFFFAOYSA-N virginiamycin-S1 Natural products CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC=CC=2)N(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O FEPMHVLSLDOMQC-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000004078 waterproofing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to an eye shadow and eye line powder block and a preparation method thereof. The powder block is prepared by adopting the combined formula of ultramicro pearl powder, lysine, vitamin E, ethylhexyl methoxycinnamate, titanium dioxide and polyvinylpyrrolidone/triacontylene copolymers as the core of the product and combining the intrinsic color expression effect of the eye shadow base material, and has dual-purpose functions of the eye shadow and the eye line, namely, the novel practical formula of the same product has dual-purpose functions of the eye shadow and the eye line. The invention provides the eye shadow and eye line dual-purpose eye shadow product having the functions of color expression, aging resistance, water resistance, sun protection and the like. Not only the eye shadow can have the functions of decoration and beauty of the traditional powder block eye shadow, but also the functional components in the eye shadow have functional effects by matching the traditional Chinese medicine with modern scientific principles, the functions of the eye liner can be fully realized when the eye liner is matched with the liquid, and no side effects exist. The powder block has reasonable formula, simple process and extremely obvious use effect.
Description
Technical field
The present invention relates to a kind of cosmetics, particularly a kind of eye shadow and eye line powder block and preparation method thereof.
Background technology
Eye shadow is a kind of common and cosmetics of conveniently using and carrying, but common eye shadow generally has only the effect of simple color representation; And the informer is used by more most women as the toiletries of present fashion.And the problem that prior art exists is exactly that the commercially available prod all only has single eye shadow or informer's function, both can not be united two into one the product that can not make consumer obtain convenient material benefit, be easy to carry about with one.Therefore, how can on identical product, realize eye shadow and informer's double-purpose functional,, promptly become one of these those skilled in the art problem anxious to be addressed for market provides a kind of application convenience, obvious results eye shadow and eye line powder block and preparation method thereof.
Summary of the invention
The objective of the invention is to overcome above-mentioned weak point, provide that a kind of technology is simple, obvious results eye shadow and eye line powder block and preparation method thereof.
Implementation of the present invention is as follows for achieving the above object:
A kind of eye shadow and eye line powder block, this product is prepared from by the composition of following mass fraction:
The composition quality umber
Lysine 1-5;
Iron oxide black 45-60;
Silicon is handled sericite 2-8;
Margarita ultrafine powder (2000 order) 5-15;
Silica 1-5;
Pulvis Talci 10-30;
Silicon is handled mica powder 5-15;
Bismuth oxychloride 0.5-5;
Iron oxide red 0.5-3;
Iso-octyl palmitate 0.5-4;
DOW CORNING 1403 silicone oil 1-5;
Dimethicone 1-4;
Vitamin E 0.1-1;
Butoben 0.1-0.5;
Octyl methoxycinnamate 0.2-1;
Titanium dioxide 3-15;
Polyvinylpyrrolidone/melene copolymer 0.5-3.
The concrete implementation step of the inventive method comprises:
Step 1: will form the color powder after aforementioned proportion Pulvis Talci, iron oxide red and the iron oxide black process micronizing;
Step 2: according to the above ratio toner after the micronizing in " step 1 " and residue powder material are comprised: lysine, silicon processing sericite, Margarita ultrafine powder, silicon dioxide, silicon processing Muscovitum, bismuth oxychloride, titanium dioxide and butoben drop into the powder blending tank and pulverize grinding; Rotating speed 2000-3000rpm, grind mixing time 3-5min, abundant batch mixing 3-5 time at every turn;
Step 3: according to the above ratio with the oily raw material, comprise: iso-octyl palmitate, DOW CORNING 1403 silicone oil, dimethicone, octyl methoxycinnamate, vitamin E and polyvinylpyrrolidone/melene copolymer carry out premixing, when stirring, the powder blending tank carries out oil spout by atomizer, rotating speed 2000-3000rpm, each mixing time 3-5min, fully batch mixing is 2-5 time;
Step 4: the powder that mixes in " step 3 " is sieved, the 40-80 order, pressed cake.
It is the commercially available prod that the present invention chooses raw material, is cosmetics-stage; Wherein Margarita ultrafine ultramicropowder, lysine, vitamin E, ethylhexyl methoxy cinnamate, titanium dioxide and new raw material polyvinylpyrrolidone/melene copolymer illustrates as main functional component and action principle thereof:
The application of combination formula in muffin class color make-up of Margarita ultrafine ultramicropowder, lysine, vitamin E, ethylhexyl methoxy cinnamate, titanium dioxide and new raw material polyvinylpyrrolidone/melene copolymer etc.: outside the Margarita ultrafine powder time spent have removing toxic substances and promoting granulation, moisten skin nutrition, suppress brown pigment, brighten, the effect of wrinkle removing, beauty treatment, skin care.Lysine is one of essential amino acid, can promote human development, raise immunity, and the effect that improves the central nervous tissue function is arranged.Vitamin E has very strong antioxidation, can prevent from fatty compound, vitamin A, selenium (Se), two kinds of sulfur aminoacid and ascorbic Oxidations and delay cell to wear out because of oxidation.The ultraviolet that studies show that the 280-320nm zone easily makes the skin sunburn, produces " solar dermatitiss " such as erythema, blisters.The p-methoxycinnamic acid esters has wide and strong absorption in the 280-320nm zone, and is non-stimulated to skin, and safety is good, is the ideal sunscreen of a class.Titanium dioxide is a kind of sunscreen that comparatively generally uses, and can reduce the skin pigment precipitation.Polyvinylpyrrolidone/melene copolymer can make color make-up have more persistent woman's persona face effect as the application of a kind of new water repellent and pigment retention adjuvant.
One, Margarita powder: be with Margaritas that shell-fish produces such as hydriopsis cumingii, cristaria plicata, pteria martensiis, grind the powder that forms, be white in color, the special fishy smell of Margarita is arranged.Ancient times, well-known doctor's Li Shizhen (1518-1593 A.D.) was put down in writing in Compendium of Material Medica: " Margarita refreshing and detoxicating, the arresting convulsion of calming the nerves remove the nebula granulation promoting ", Margarita is used to treat multiple disease always in traditional tcm prescription.Oral Margarita powder can be treated coronary heart disease, hypertension, arrhythmia, diabetes, insomnia headache, gastroenteritis etc.The external application Margarita powder can be treated knife injury, scalds, and wound bleedings such as burn fester and oral ulcer pharyngolaryngitis etc.Oral and external Margarita powder can also make skin moisten and whiten, and wrinkle removing is anti-ageing, eliminates mottle, has the effect of significant skin maintenance.Margarita is exactly a skin care treasure rare in the aesthetic health care field from ancient times, is described as beautiful classics.Moist beautiful sea water pearls is more asked the superfine product that becomes in the treasure because of matter height, difficulty.
Confirm through modern medicine study: " contain 19 seed amino acids, nearly 20 kinds of mineral and high-activity biological taurine and the pearl protein that enriches and a large amount of trace element in the Margarita; can improve the activity of flight against senium of human body factor S OD and amino acid carrier GSH-PX, have the effect of the arresting convulsion of calming the nerves, heat-clearing and toxic substances removing, soothing the liver hepatoprotective, the intestines and stomach coordinating, additional calcium system, trace element supplement; While energy delaying skin aging, speckle dispelling, anti-acne, crease-resistant strengthen skin gloss and elasticity; By regulating human endocrine, enhance metabolism and multiple function such as enhancing human body immunity power.
(1) immunomodulating, slow down aging: Margarita powder contains profuse nutrient substance, and it provides comprehensive logistics support with the nutrition of the comprehensive nourishing human body disappearance of gentle pharmacology, can improve body immunity in all directions, the prevention slow down aging.The contained manganese of Margarita powder, copper, zinc can be removed free radical, strengthen the human body vitality, prevent the aging of body cell premature oxidation; Tool good isolation protection of Margarita powder institute and radiation resistance can protect skin to exempt to be tanned severely, thus anti-delaying skin aging.
(2) whitening and speckle dispelling: the nutritional labeling that Margarita is rich in can suppress the activity of tyrosine and tryrosinase, stops it to send and forms melanic signal, reaches and suppresses the effect that melanin forms.Margarita powder for oral administration simultaneously can be regulated the organism endocrine function, and it is external that calm melanin in epidermal area is got rid of fast, thus reach whiten, the effect of speckle dispelling.
(3) preserve moisture: contain multiple aminosal by the Margarita powder of concocting, very close with the protein structure of normal human skin, molecular weight is lower, so easily by skin absorbs, thereby promote the cell growth, the repair of skin damage.Simultaneously, this material is a kind of natural conditioning factor, can be adsorbed in to form water-retaining property thin film preferably on the exsiccant skin, has the effect of good nutrition and protection flesh.
(4) anti-acne: Margarita powder has good especially anti-inflammation and sterilization effect, the effect of its " convergence granulation promoting " can be accelerated the damaged skin healing simultaneously, and can promote new proliferation of cells speed, oral Margarita powder more can heat clearing away, toxin expelling, thereby really from accomplish not trace of Margarita anti-acne at all.
Two, lysine: the chemical constitution skeleton symbol is H
2NCH
2CH
2CH
2CH
2CH (NH
2) COOH.The free-pouring crystalline powder of white or near-white.Odorless almost.263-264 ℃ of fusing also decomposed.Usually more stable, high-temperature easily lumps down, and is painted slightly.Stable when relative humidity 60% is following, then generate dihydrate more than 60%.Then painted with vitamin C and vitamin K3 coexistence.Heating is then decomposed under alkali condition and direct and the reducing sugar existence.It is neutral to subacidity that (40g/100ml, 35 ℃) soluble in water, aqueous solution are, and with heating such as phosphoric acid, hydrochloric acid, sodium hydroxide, ion exchange resin, plays racemization.
Lysine is essential amino acids, then causes the protein metabolism dysfunction as lacking, and causes retardation of growth.Lysine is alkaline essential amino acids.Lysine is one of essential amino acid, can promote human development, raise immunity, and the effect that improves the central nervous tissue function is arranged.Because the lysine content in the cereal foods is very low, and easily destroyed in the course of processing, so be called first limiting amino acid.
Lysine can be regulated the human body metabolic balance.Lysine provides structural constituent for synthetic carnitine, and carnitine can impel the synthetic of fatty acid in the cell.In food, add a spot of lysine, can stimulate the secretion of pepsin and gastric acid, improve the gastric secretion effect, play the effect of appetite stimulator, promotion physical growth of children and growth.Lysine can also improve the absorption of calcium and accumulation in vivo thereof, quickens bone growth.As lack lysine, and can cause gastric secretion not enough and anorexia, nutritional anemia occur, cause that nervus centralis is obstructed, dysplasia.
Lysine is the seed amino acid that human body needs, a kind of indispensable nutrient substance.People know, protein is the Main Ingredients and Appearance that constitutes human body cell, protein in the food resolves into aminoacid earlier through digestion after entering human body, human body utilizes the new human body protein of these aminoacid resynthesis again then, all is human body protein after synthetic as immune antibody, digestive enzyme, plasma protein, growth hormone etc.In each seed amino acid of synthetic protein, L-lysine is most important a kind of, has lacked it, and other aminoacid just is restricted or is not used, and scientist claims that it is human body first essential amino acids.In recent years, scientist also finds, L-lysine is that the important substance of control people bulk-growth presses down that long plain (Somatotation, most important in ss) also is the most essential composition, and people's nervus centralis and peripheral nervous system all played an important role.Human body can not self synthesize L-lysine, must draw lysine from food is the key substance that helps other nutrient substance fully to be absorbed and utilize by human body, human body has only and has replenished absorption and the utilization that enough L-lysine could improve food protein, reach balanced nutritious, promote growth promoter.Its effect has:
(1) improves intelligence, promotion growth, health invigorating.
(2) appetite stimulator, improve the malnutrition situation.
(3) improve insomnia, improving memory.
(4) help to produce antibody, hormone and enzyme, improve immunity, increase hematochrome.
(5) absorption of help calcium, treatment prevents osteoporosis
(6) level of triglyceride in the reduction blood, the generation of prevention cardiovascular and cerebrovascular disease.
Three, polyvinylpyrrolidone/melene copolymer (ANTARONWP-660): alkyl polyvinylpyrrolidone product line is used for skin care item and the cosmetics prescription can bring tangible benefit to the user, all comparatively obvious from water resistance and persistent dressing effect, polyvinylpyrrolidone/melene copolymer is a kind of comparatively effectively waterproof ingredient.The ANTARON polymer-derived is from vinyl pyrrolidone and long-chain alpha alkene, INCI called after polyvinylpyrrolidone/melene copolymer of ANTARONWP-660, for the chip solid activity value greater than 98%, HLB valuation 3-5, nitrogen content 2.0-3.0, freezing point is 58-68 ℃. the employing adhesive plaster is peeled off the residual waterproofing agent of skin surface after the method metering gets wet, and the result shows both can show excellent performance when the consumption of ANTARONWP-660 is 5%.
At these two kinds of different cosmetics of eye shadow and informer, the present invention has set forth and a kind ofly can increase the eye glamour with traditional eye shadow for what use convenient for female designed, play and modify the eye lines, make eyes that god more be arranged, is rich in relief effect, and powder agglomates can be used as the liquid eye-liner and uses when collocation informer brush and liquid use, can be used to deepen and the color make-up effect of outstanding eye, make eyes look big and refreshing dual-purpose eye shadow prescription is arranged, compare with product in the market, prescription is with " Margarita ultrafine ultramicropowder; lysine; vitamin E; ethylhexyl methoxy cinnamate; the combination formula of titanium dioxide and the polyvinylpyrrolidone/melene copolymer etc. " core as product, and the inherent color representation effect of cooperation eye shadow base material, formulated realization eye shadow and informer's double-purpose functional, both eye shadow and informer's the two novel practical prescriptions that are used in identical product.
The invention has the beneficial effects as follows:
Common eye shadow powder agglomates generally only has simple color modification, the invention provides and a kind ofly can and can play the dual-purpose eye shadow prescription of the informer effect of aging resistance, waterproof, anti-sunlight function with traditional eye shadow color representation effect for what use convenient for female designed, this eye shadow not only can play the Spanish furnish effect, and the cooperation of utilization Chinese medicine and modern science principle makes functional component wherein also have functional effect.
The function of eye shadow: powder agglomates can increase the eye glamour when the collocation eye-lash uses, play and modify the eye lines, makes eyes that god more be arranged, and is rich in relief effect.
Informer's function: powder agglomates can be used as the liquid eye-liner and uses when collocation informer brush and liquid use, and can be used to deepen and the color make-up effect of outstanding eye, makes eyes look big and god is arranged, more beauty.
More can realize informer's function when collocation informer brush uses with liquid, simultaneously, no any chemical harmful substance can not produce any side effect in its constituent.
In a word, the present invention fills a prescription rationally, and technology is simple, the result of use highly significant.
The specific embodiment
Below in conjunction with preferred embodiment, to according to the specific embodiment provided by the invention, details are as follows for feature:
Every part of embodiment 1:(is by 10g)
A kind of eye shadow and eye line powder block, this product is prepared from by the composition of following mass fraction:
Composition weight (g)
Lysine 10;
Iron oxide black 500;
Silicon is handled sericite (powdery) 80;
Margarita ultrafine powder (2000 order) 50;
Silicon dioxide 30;
Pulvis Talci 200;
Silicon is handled Muscovitum 150;
Bismuth oxychloride 5;
Iron oxide red 15;
Iso-octyl palmitate 40;
DOW CORNING 1403 silicone oil 10;
Dimethicone 25;
Vitamin E 10;
Butoben 1;
Octyl methoxycinnamate 25;
Titanium dioxide 150;
Polyvinylpyrrolidone/melene copolymer 5.
DOW CORNING 1403 silicone oil are the commercially available prod, the INCI title: polydimethyl siloxanes/polydimethy siloxanes alcohol is that the hyperviscosity dimethiconol mixes a kind of solution in the low viscosity polydimethylsiloxane.After allocating product into, can form the breathable film of refusing water, thereby improve the affinity of active component, increase and to sprawl uniformity, with after give silkiness smooth and increase aesthetic feeling.Dimethiconol content 12-14%, polydimethylsiloxane 86-88%.
Preparation method of the present invention:
Step 1: will form the color powder after aforementioned proportion Pulvis Talci, iron oxide red and the iron oxide black process micronizing;
Step 2: according to the above ratio toner after the micronizing in " step 1 " and residue powder material are comprised: lysine, silicon processing sericite, Margarita ultrafine powder, silicon dioxide, silicon processing Muscovitum, bismuth oxychloride, titanium dioxide and butoben drop into the powder blending tank and pulverize grinding; Rotating speed 2000-3000rpm, grind mixing time 3-5min, abundant batch mixing 3-5 time at every turn;
Step 3: according to the above ratio with the oily raw material, comprise: iso-octyl palmitate, DOW CORNING 1403 silicone oil, dimethicone, octyl methoxycinnamate, vitamin E and polyvinylpyrrolidone/melene copolymer carry out premixing, when stirring, the powder blending tank carries out oil spout by atomizer, rotating speed 2000-3000rpm, each mixing time 3-5min, fully batch mixing is 2-5 time;
Step 4: the powder that mixes in " step 3 " is sieved, the 40-80 order, pressed cake.
Every part of embodiment 2:(is by 10g)
Composition weight (g)
Lysine 30;
Iron oxide black 600;
Silicon is handled sericite (powdery) 20;
Margarita ultrafine powder (2000 order) 100;
Silicon dioxide 50;
Pulvis Talci 100;
Silicon is handled mica powder 100;
Bismuth oxychloride 50;
Iron oxide red 5;
Iso-octyl palmitate 20;
DOW CORNING 1403 silicone oil 50;
Dimethicone 10;
Vitamin E 5;
Butoben 5;
Octyl methoxycinnamate 1;
Titanium dioxide 90;
Polyvinylpyrrolidone/melene copolymer 30.
Preparation method and other are with embodiment 1.
Every part of embodiment 3:(is by 10g)
Composition weight (g)
Lysine 50;
Iron oxide black 450;
Silicon is handled sericite (powdery) 50;
Margarita ultrafine powder (2000 order) 150;
Silica 10;
Pulvis Talci 200;
Silicon is handled mica powder 150;
Bismuth oxychloride 5;
Iron oxide red 15;
Iso-octyl palmitate 40;
DOW CORNING 1403 silicone oil 10;
Dimethicone 25;
Vitamin E 10;
Butoben 1;
Octyl methoxycinnamate 25;
Titanium dioxide 150;
Polyvinylpyrrolidone/melene copolymer 5.
Preparation method and other are with embodiment 1.
The effect explanation: this product has used the combination formula of Margarita ultrafine powder and lysine, and when having the skin-care effect of looks improving and the skin nourishing, product has had concurrently and suppressed ultraviolet to the infringement of skin and sun-proof effect.Common eye shadow powder agglomates generally only has simple color modification, the invention provides and a kind ofly can and can play aging resistance with traditional eye shadow color representation effect for what use convenient for female designed, waterproof, the dual-purpose eye shadow prescription of informer's effect of anti-sunlight function, this eye shadow not only can play the Spanish furnish effect, the cooperation of utilization Chinese medicine and modern science principle makes functional component wherein also have functional effect, when using with liquid, more can realize by collocation informer brush informer's function, water resistance is outstanding when using as the informer, and woman's persona face effect is lasting.No any chemical harmful substance can not produce any side effect in its constituent.The compounded combination that Margarita ultrafine powder, lysine and polyvinylpyrrolidone/melene copolymer is formed both can increase eye nutrition, the skin sense is fine and smooth after use, can have waterproof action concurrently again, make a kind of product reach double effects, easy to use when practical application, be easy to makeup, can make that the eye dressing is not dizzy dyes, make powder face effect more docile.
Above-mentioned with reference to embodiment to the detailed description that this eye shadow and eye line powder block and preparation method thereof carries out, be illustrative rather than determinate; Therefore in the variation and the modification that do not break away under the general plotting of the present invention, should belong within protection scope of the present invention.
Claims (2)
1. eye shadow and eye line powder block is characterized in that this eye shadow and eye line powder block is prepared from by the composition of following mass fraction:
The composition quality umber
Lysine 1-5;
Iron oxide black 45-60;
Silicon is handled sericite 2-8;
Margarita ultrafine powder 5-15;
Silica 1-5;
Pulvis Talci 10-30;
Silicon is handled mica powder 5-15;
Bismuth oxychloride 0.5-5;
Iron oxide red 0.5-3;
Iso-octyl palmitate 0.5-4;
DOW CORNING 1403 silicone oil 1-5;
Dimethicone 1-4;
Vitamin E 0.1-1;
Butoben 0.1-0.5;
Octyl methoxycinnamate 0.1-5;
Titanium dioxide 3-15;
Polyvinylpyrrolidone/melene copolymer 0.5-3.
2. the preparation method of an eye shadow and eye line powder block according to claim 1 is characterized in that the concrete implementation step of this method comprises:
Step 1: will form the color powder after aforementioned proportion Pulvis Talci, iron oxide red and the iron oxide black process micronizing;
Step 2: according to the above ratio toner after the micronizing in " step 1 " and residue powder material are comprised: lysine, silicon processing sericite, Margarita ultrafine powder, silicon dioxide, silicon processing Muscovitum, bismuth oxychloride, titanium dioxide and butoben drop into the powder blending tank and pulverize grinding; Rotating speed 2000-3000rpm, grind mixing time 3-5min, abundant batch mixing 3-5 time at every turn;
Step 3: according to the above ratio with the oily raw material, comprise: iso-octyl palmitate, DOW CORNING 1403 silicone oil, dimethicone, octyl methoxycinnamate, vitamin E and polyvinylpyrrolidone/melene copolymer carry out premixing, when stirring, the powder blending tank carries out oil spout by atomizer, rotating speed 2000-3000rpm, each mixing time 3-5min, fully batch mixing is 2-5 time;
Step 4: the powder that mixes in " step 3 " is sieved, the 40-80 order, pressed cake.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010148669 CN101780026B (en) | 2010-04-16 | 2010-04-16 | Eye shadow and eye line powder block and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010148669 CN101780026B (en) | 2010-04-16 | 2010-04-16 | Eye shadow and eye line powder block and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101780026A true CN101780026A (en) | 2010-07-21 |
| CN101780026B CN101780026B (en) | 2012-08-08 |
Family
ID=42520257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201010148669 Expired - Fee Related CN101780026B (en) | 2010-04-16 | 2010-04-16 | Eye shadow and eye line powder block and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101780026B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102670475A (en) * | 2012-06-12 | 2012-09-19 | 无锡丝源化妆品有限公司 | Pearl powder eye shadow cream |
| CN107519027A (en) * | 2017-09-01 | 2017-12-29 | 郝庆好 | Dumb light elasticity eye shadow and preparation method thereof |
| CN108295017A (en) * | 2018-02-06 | 2018-07-20 | 陈云 | A kind of drop resistant eye shadow block and preparation method thereof |
| CN112618388A (en) * | 2021-01-06 | 2021-04-09 | 福建东亮生物科技有限公司 | Low-heavy metal eye shadow formula and processing technology |
| CN114788808A (en) * | 2022-05-12 | 2022-07-26 | 广州多多化妆品有限公司 | Agile rainbow eyeliner and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1367911A (en) * | 1999-07-07 | 2002-09-04 | Fd管理公司 | Colour cosmetic selection system |
| CN1512870A (en) * | 2001-06-05 | 2004-07-14 | 宝洁公司 | Film forming cosmtic compositions |
| CN101273958A (en) * | 2007-03-29 | 2008-10-01 | 维尔维廷布尼有限公司 | Cosmetic and dermatological formulations with natural pigments and methods of use |
-
2010
- 2010-04-16 CN CN 201010148669 patent/CN101780026B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1367911A (en) * | 1999-07-07 | 2002-09-04 | Fd管理公司 | Colour cosmetic selection system |
| CN1512870A (en) * | 2001-06-05 | 2004-07-14 | 宝洁公司 | Film forming cosmtic compositions |
| CN101273958A (en) * | 2007-03-29 | 2008-10-01 | 维尔维廷布尼有限公司 | Cosmetic and dermatological formulations with natural pigments and methods of use |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102670475A (en) * | 2012-06-12 | 2012-09-19 | 无锡丝源化妆品有限公司 | Pearl powder eye shadow cream |
| CN107519027A (en) * | 2017-09-01 | 2017-12-29 | 郝庆好 | Dumb light elasticity eye shadow and preparation method thereof |
| CN108295017A (en) * | 2018-02-06 | 2018-07-20 | 陈云 | A kind of drop resistant eye shadow block and preparation method thereof |
| CN112618388A (en) * | 2021-01-06 | 2021-04-09 | 福建东亮生物科技有限公司 | Low-heavy metal eye shadow formula and processing technology |
| CN114788808A (en) * | 2022-05-12 | 2022-07-26 | 广州多多化妆品有限公司 | Agile rainbow eyeliner and preparation method thereof |
| CN114788808B (en) * | 2022-05-12 | 2023-11-28 | 广州多多化妆品有限公司 | Agile rainbow eyeliner and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101780026B (en) | 2012-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101780025B (en) | Beautifying and whitening sun protection pressed powder and preparation method thereof | |
| CN101151066B (en) | Use of an orally administered dietary supplement for regulating the cosmetic appearance of human keratinous tissue | |
| CN101773241A (en) | Nano blood-tonifying face-nursing health food and production method thereof | |
| CN101773463A (en) | Selenium-enriched nano pearl powder formula and production method thereof | |
| CN101773464A (en) | Nano whitening anti-wrinkle speckle-removing blain-removing formula and production method thereof | |
| CN101780026B (en) | Eye shadow and eye line powder block and preparation method thereof | |
| CN103919711B (en) | A kind of anti-ageing whitening cream of oolong tea and manufacture method thereof | |
| CN101961303B (en) | Facial mask and preparation method thereof | |
| CN103565728A (en) | Lycium ruthenicum mill whitening and moisturizing smoothing toner and preparation method of smoothing toner | |
| CN101199461A (en) | Skin-protecting and hair-protecting products containing prinsepia utilis royle oil | |
| CN103340817A (en) | Radix puerariae whitening facial mask | |
| CN102823691A (en) | Detoxification beautification tea | |
| CN109248135A (en) | A kind of sheen highlights, the external-use skin care of concealing moisturizing combination and preparation method thereof | |
| CN102783649B (en) | Functional food with nourishing and slimming functions and preparation method thereof | |
| CN105250199A (en) | Edible facial mask containing pearl powder | |
| CN107048385A (en) | A kind of composition with blackening and generating hair function and preparation method thereof | |
| CN101317908B (en) | Skin-protection liquid formula containing pomelo ped juice | |
| CN108578296B (en) | Anti-aging traditional Chinese medicine extract composition, preparation method thereof and application thereof in cosmetics | |
| CN104013549B (en) | Skin care product containing lethariella sinensis extract | |
| CN109330925A (en) | A kind of pure natural seaweed clay mask and preparation method thereof | |
| CN107669607A (en) | A kind of facial mask and preparation method thereof | |
| CN106491477A (en) | A kind of skin care item and preparation method thereof | |
| CN112426389A (en) | Production process of red cherry lipstick | |
| CN105769659A (en) | Edible collagen membrane and preparation method thereof | |
| CN109646359A (en) | Rose-agaric mud membrane paste with effects of cleaning, purifying, maintaining beauty and keeping young and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120808 |